Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sale Of Pfizer’s Established Products Not Off The Table, Exec Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer CFO Frank D’Amelio talks about the big pharma’s long-term vision and cost-reduction initiatives during the Morgan Stanley Healthcare conference. Management will continue reviewing the portfolio on an ongoing basis to see how best to maximize shareholder value, he said.

Advertisement

Related Content

Entering The Generics Business In Mature Markets: Lessons Learned From 4,500 Launches
Pfizer To Purchase NextWave For ADHD Drug
Pfizer Moo’ved To Split Off Zoetis Business By July 2013
Pfizer Sells Nutrition Portfolio To Nestle For Nearly $12B
Pfizer: Established Products And Consumer Health In; Animal Health And Nutrition Out
For Pfizer Chief, The First Order Of Business Is Research

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel